NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Collections Health Policy and Services Research Remove constraint Collections: Health Policy and Services Research Subjects United States. Food and Drug Administration. Remove constraint Subjects: United States. Food and Drug Administration. Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later Publication Year 2000 to 2024 Remove constraint Publication Year: <span class="from" data-blrl-begin="2000">2000</span> to <span class="to" data-blrl-end="2024">2024</span>

Search Results

232. Testing of retroviral vector-based human gene therapy products for replication competent retrovirus during product manufacture and patient follow-up

234. Human gene therapy for hemophilia

236. Use of serological tests to reduce the risk of transfusion-transmitted human T-lymphotropic virus types I and II (HTLV-I/II)

239. Recommendations for clinical laboratory improvement amendments of 1988 (CLIA) waiver applications for manufacturers of in vitro diagnostic devices: guidance for industry and Food and Drug Administration staff

240. Recommendations for dual 510(k) and CLIA waiver by application studies: guidance for industry and Food and Drug Administration staff